Table 1.

Pretreatment Characteristics

Characteristic	Arm 1 (n = 477)		Arm 2 (n = 468)		P
	No. of Patients	%	No. of Patients	%
Age, years
< 70	230	48	223	48	.86
≥ 70	247	52	245	52
Prevalent CVD
No	342	72	345	74	.45*
Yes	133	28	120	26
Unknown	2	< 1	3	1
Prevalent HTN
No	323	68	309	66	.58*
Yes	152	32	157	34
Unknown	2	< 1	2	< 1
Prevalent DM
No	392	82	373	80	.24*
Yes	36	8	45	10
Unknown	49	10	50	11
BMI
Missing	74	16	83	18
Available	403	84	385	82
BMI category, kg/m2
< 25	132	33	109	28	.40
≥ 25 to < 30	200	50	202	52
≥ 30	71	18	74	19
Race
White	429	90	422	90	.71†
Black	43	9	39	8
Other	5	1	7	2
Prostatectomy
No	406	85	400	85	.88
Yes	71	15	68	15
Nodal involvement
No	337	71	345	74	.29
Yes	140	29	123	26
Acid phosphatase
Not elevated	318	67	316	68	.78
Elevated	159	33	152	32
Gleason score (central)
Missing	41	9	42	9
Available	436	91	426	91
2-6	125	29	129	30	.82
7	172	39	160	38
8-10	139	32	137	32
Clinical stage
A/B	141	30	127	27	.41
C	336	70	341	73

Abbreviations: CVD, cardiovascular disease; HTN, hypertension; DM, diabetes mellitus; BMI, body mass index.

^*Comparison of no v yes.

^†Comparison of white/other v black.